GEMMABio Receives ARPA-H Grant for Precision Gene Editing
PHILADELPHIA, Pennsylvania, USA, July 9, 2026 GEMMA Biotherapeutics (GEMMABio) has been awarded funding from the Advanced Research Projects Agency...
Advertisement
HDT Bio Advances HDT-401 into Phase 1 Glioblastoma Trial
MONTREAL, Canada / SEATTLE, Washington, July 12, 2026 HDT Bio Corp. has launched a major Canadian clinical development initiative...
Xeltis Launches aXess Commercial Rollout
EINDHOVEN, The Netherlands, July 7, 2026 Xeltis has announced the first commercial implantation of its aXess™ vascular access device,...
AB Science Prioritizes AML and ALS Programs
PARIS, July 10, 2026 AB Science announced a major strategic update to its clinical development pipeline, confirming that it...
Eisai and Biogen Advance LEQEMBI SC for Alzheimer’s Disease
TOKYO, Japan / CAMBRIDGE, Massachusetts, USA, July 12, 2026 Eisai Co., Ltd. and Biogen Inc. have announced new clinical...
Conavi Showcases Clinical Imaging Evidence
TORONTO, July 8, 2026 Conavi Medical Corp. announced the publication of a clinical case report in the Journal of...
Theranica Expands Nerivio Coverage Across U.S. Insured Population
BRIDGEWATER, New Jersey, USA / CAESAREA, Israel, July 9, 2026 Theranica has announced a major reimbursement milestone for Nerivio®,...
Spectral AI Names Darcy Bajko Launch Leader
DALLAS, July 8, 2026 Spectral AI, Inc. announced the appointment of Darcy Bajko as Chief Commercial Officer, effective July...
Novo Nordisk’s Denecimig Shows Strong Phase 3 Hemophilia Data
PLAINSBORO, New Jersey, USA / BAGSVÆRD, Denmark, July 11, 2026 Novo Nordisk has announced positive long-term Phase 3 results...
FDA Proposes New Rule to Modernize Drug Manufacturing
SILVER SPRING, Maryland, July 10, 2026 The U.S. Food and Drug Administration (FDA) has proposed a new rule designed...
Advertisement
